Skip to main content

Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice.

Author
Abstract
:

Binge eating disorder (BED) is the most common eating disorder and was newly recognized in 2013 in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). BED is frequently associated with obesity and the metabolic syndrome, as well as with other psychiatric diseases, such as mood (49%), anxiety (41%), and substance use (22%) disorders. BED is highly prevalent and carries a high burden of mental and physical illness and disability. However, BED is frequently under-recognized and under-treated.

Year of Publication
:
2019
Journal
:
Expert opinion on pharmacotherapy
Volume
:
20
Issue
:
6
Number of Pages
:
679-690
ISSN Number
:
1465-6566
URL
:
http://www.tandfonline.com/doi/full/10.1080/14656566.2019.1571041
DOI
:
10.1080/14656566.2019.1571041
Short Title
:
Expert Opin Pharmacother
Download citation